Showing results (1201-1210 of 1,347) with videos related to

Sort By:
Pageof 135
Endocrinology|September 29, 1998
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivoM Rossi, M S Kim, D G Morgan, et al.
Blood|August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.
Vaccine|July 9, 2013
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in malesStephen E Goldstone, Heiko Jessen, Joel M Palefsky, et al.
Journal of Medicinal Chemistry|December 6, 2023
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid ModulatorsShujing Xu, Lin Sun, Michael Barnett, et al.
Annals of Neurology|June 3, 2017
Serum insulin-like growth factor-I levels are associated with improved white matter recovery after traumatic brain injuryClaire Feeney, David J Sharp, Peter J Hellyer, et al.
JTCVS Open|July 1, 2026
Surgical-site infections in infants undergoing surgery for congenital heart disease during their first year of lifeWooJin Shin, Ami Patel, Luis Alba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignanciesKatharine Branson, Rajesh Chopra, Panagiotis D Kottaridis, et al.
Neuron|August 5, 2003
Local tissue interactions across the dorsal midline of the forebrain establish CNS lateralityMiguel L Concha, Claire Russell, Jennifer C Regan, et al.
Surgical Endoscopy|May 23, 2024
Oncologic outcomes following transanal total mesorectal excision: the United States experienceMakda Getachew Zewde, Daniel K Peyser, Allen T Yu, et al.
Clinical and Vaccine Immunology : CVI|December 14, 2011
Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years oldRichard J Hillman, Anna R Giuliano, Joel M Palefsky, et al.
Pageof 135